Brewed chicory leaf consumption has unexpected side effects along beneficial effects on liver enzymes in non-alcoholic fatty liver disease patients
Introduction: This randomized controlled trial study aimed to find the benefits and possible side effects of brewed chicory leaf consumption in non-alcoholic fatty liver disease (NAFLD) patients. Methods Sixty NAFLD patients were randomly allocated into intervention and control groups and consumed brewed chicory leaf made from 15 g chicory leaf along with usual treatment or only the usual treatment, respectively. This study was planned for 12 weeks, but it was stopped in the sixth week due to unexpected side effects. Results After 6 weeks, total bilirubin, ALT and AST in the intervention group were significantly reduced compared to the control group (p < 0.05). In the intervention group compared to the control group we observed a significant increase in number of red blood cells (0.16 ± 0.33 vs. −0.01 ± 0.27, p = 0.026), platelets (34.00 ± 45.55 vs. 7.96 ± 25.30, p = 0.014), hemoglobin (0.37 ± 0.84 vs. −0.09 ± 0.59, p = 0.018), fasting blood sugar (5.85 ± 8.47 vs. 0.29 ± 6.67, p = 0.017), total cholesterol (14.08 ± 20.80 vs. −1.30 ± 4.42, p = 0.001), low-density lipoprotein (15.36 ± 20.02 vs. −0.17 ± 6.70, p < 0.0001), and a significant decrease in the mean platelet volume (−3.03 ± 1.79 vs. 0.01 ± 0.62, p < 0.0001). Discussion Consumption of brewed chicory leaf could have unexpected side effects on people with NAFLD. (IRCT20190819044565N2)
